OPPTF
NBIX icon

OPSEU Pension Plan Trust Fund’s Neurocrine Biosciences NBIX Stock Holding History

OPSEU Pension Plan Trust Fund’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,576
Closed -$737K – 293
2021
Q1 		$737K Buy
7,576
+246
+3% +$25.8K 0.19% 213
2020
Q4 		$699K Sell
7,330
-1,698
-19% -$164K 0.2% 210
2020
Q3 		$855K Sell
9,028
-80
-0.9% -$9.25K 0.27% 162
2020
Q2 		$1.14M Buy
+9,108
New +$1.01M 0.39% 96

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.84B AUM 22.63% 1-Year Est. Return

OPSEU Pension Plan Trust Fund's NBIX Position: Q2 2021 in Review

OPSEU Pension Plan Trust Fund sold out of Neurocrine Biosciences (NBIX) in Q2 2021, closing a stake of 7,576 shares — an estimated $737K sold.

OPSEU Pension Plan Trust Fund first reported a position in NBIX in Q2 2020 and held it in 4 quarters. The position peaked at $1.14M in Q2 2020. 409 funds tracked by Wall St. Rank hold NBIX as of Q2 2021.

  • OPSEU Pension Plan Trust Fund reported no remaining Neurocrine Biosciences position as of Q2 2021 after selling out during the quarter.
  • OPSEU Pension Plan Trust Fund sold 7,576 Neurocrine Biosciences shares in Q2 2021, an estimated $737K.
  • OPSEU Pension Plan Trust Fund first reported a position in Neurocrine Biosciences in Q2 2020 and held it in 4 quarters.
  • OPSEU Pension Plan Trust Fund's Neurocrine Biosciences position peaked at $1.14M in Q2 2020.
  • 409 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2021.

Based on OPSEU Pension Plan Trust Fund's 13F filing for Q2 2021, filed 11 Aug 2021.